Denis M. Collins

Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines

Denis M. Collins, Norma O’Donovan, Patricia M. McGowan et al. · Annals of Oncology · 2011 · 140 citations · Full text

Src: a potential target for the treatment of triple-negative breast cancer

Dimitrios Tryfonopoulos, S. Walsh, Denis M. Collins et al. · Annals of Oncology · 2011 · 139 citations

Breast Oncology, Medicine, Pathology +8

Novel Strategies for Cancer Treatment: Highlights from the 55th IACR Annual Conference

Sara Charmsaz, Denis M. Collins, Antoinette S. Perry et al. · Cancers · 2019 · 73 citations · Full text

Epigenetic Therapies, Conventional Therapies, Cancer Management +21

Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors

Neil T. Conlon, Jeffrey J. Kooijman, Suzanne J.C. van Gerwen et al. · British Journal of Cancer · 2021 · 68 citations · Full text

Effects of HER Family–targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer

Denis M. Collins, Stephen F. Madden, Nicola Gaynor et al. · Clinical Cancer Research · 2020 · 66 citations · Full text